Item 5. Other Information
Item
5. Other Information
None.
Securities
Trading Plans of Directors and Executive Officers
No
officers or directors, as defined in Rule 16a-1(f), adopted or terminated a
“Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,”
as defined in Regulation S-K Item 408, during the fiscal quarter ended March
31, 2025.
Item 6. Exhibits
Exhibit Number
Description of Document
Note Reference
31.1*
Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
31.2*
Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
32.1**
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS
Inline XBRL Instance Document** (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
27
Index
Exhibit
Number
Description of Document
Note
Reference
101.SCH
Inline XBRL Taxonomy Extension Schema Document**
101.CAL
Inline XBRL Taxonomy Calculation Linkbase Document**
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document**
101.LAB
Inline XBRL Taxonomy Label Linkbase Document**
101.PRE
Inline XBRL Taxonomy Presentation Linkbase Document**
104*
Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document and included in Exhibit 101)
*
Filed herewith.
**
Furnished herewith and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
28
Index
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on May 15, 2025.
GALECTIN THERAPEUTICS INC.
By:
/s/ Joel Lewis
Name:
Joel Lewis
Title:
Chief Executive Officer and President
(principal executive officer)
By:
/s/ Jack W. Callicutt
Name:
Jack W. Callicutt
Title:
Chief Financial Officer
(principal financial and accounting officer)
29
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.